169
Participants
Start Date
December 11, 2017
Primary Completion Date
December 1, 2020
Study Completion Date
December 1, 2020
BIIB111
Administered as specified in the treatment arm.
Research Site, New York
Research Site, Baltimore
Research Site, Miami
Research Site, Cincinnati
Research Site, Bonn
Research Site, Madison
Research Site, Dallas
Research Site, Los Angeles
Research Site, Portland
Research Site, Montreal
Research Site, Vancouver
Research Site, Glostrup Municipality
Research Site, Montpellier
Research Site, Tübingen
Research Site, Nijmegen
Research Site, Helsinki
Research Site, Manchester
Research Site, Oxford
Lead Sponsor
Biogen
INDUSTRY